Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors

NCT02746081 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
81
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer